RLM.L Regulatory News (RLM)

11 Jun 2007 14:32

PuriCore Plc11 June 2007 11 June 2007 PuriCore plc presenting at Piper Jaffray Annual London Global Healthcare Conference MALVERN, PENNSYLVANIA, AND STAFFORD, UK - PuriCore (LSE: PURI), the lifesciences company focused on the development and commercialization of its novel,safe antimicrobial technology, today announces that its Chief Executive Officer,Greg Bosch, will be presenting at the Piper Jaffray Healthcare Conference at theGreat Eastern Hotel, London on 21st June 2007. Contacts: PuriCore plc +1 (484) 321 2700Greg Bosch, Chief Executive OfficerKeith A. Goldan, Chief Financial Officer Financial Dynamics +44 (0) 20 7831 3113Ben BrewertonJohn Gilbert About PuriCore PuriCore (London Stock Exchange: PURI) is a life sciences company focused ondeveloping and commercializing proprietary products that safely, effectively,and naturally kill contagious pathogens. PuriCore's technology mimics the humanbody's production of the natural antimicrobial hypochlorous acid, which ishighly effective in killing bacteria, viruses, and fungal spores. PuriCore'stechnology provides a potential solution in a broad range of markets that dependupon controlling contamination, including food safety, medical devicedisinfection, wound management, and hospitality. Deploying hypocholous acidsolutions as soaks, sprays, mists and in other forms, PuriCore's technology isdesigned to limit the spread of infectious disease, including major publichealth threats of Tuberculosis, MRSA, E.coli, norovirus, avian influenza, HIV,polio virus, Helicobater pylori, and Legionella. To receive additional information on PuriCore, please visit our web site atwww.puricore.com, which does not form part of this press release. This information is provided by RNS The company news service from the London Stock Exchange